Mayo Clinic November 15, 2021
John Halamka

Combining genetic sequencing, life-style modification, and personalized drug therapy will transform health care.

John Halamka, M.D., president, Mayo Clinic Platform, and Paul Cerrato, senior research analyst and communications specialist, Mayo Clinic Platform, wrote this article.

While still prevalent, the one-size-fits-all health care is slowly giving way to a more precise, personalized approach that takes into account each person’s unique environmental and genetic risk factors. For that transformation to reach its full potential, it will require the use of several emerging tools that give each patient a unique “topographical map” to navigate the journey. Most of the health care events in our lives involve a set of experiences determined by our phenotype, genotype, and exposome. Some diagnoses are determined by...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Digital Health, EMR / EHR, Health IT, Healthcare System, Patient / Consumer, Pharma / Biotech, Precision Medicine, Provider, Technology
IU Health operating income drops 66% to $15.4M in Q1
UC Davis Health to trim workforce
HCA CFO sees 'encouraging signs' from 2-midnight rule
MGMA seeks clarity on breach notification burden in wake of Change cyberattack
Labor Department's new salaried overtime rule: What healthcare leaders should know

Share This Article